Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJ5Q2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,275
Award facts
- Contract value 100% obligated
- $10,274.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,274.80 firm fixed-price delivery order to AmerSourceBergen Drug Corp (parent company Cencora, Inc.) on January 23, 2026, for Dupixent 300 mg/2 ml pen injections with a completion date of January 26, 2026. The contract is not set-aside and represents a competitively awarded delivery order for pharmaceutical supply to support federal medical procurement needs. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor in the Defense Logistics Agency's Medical Supply Chain, with performance of work occurring at the company's Conshohocken facility.
This delivery order is issued under AmerSourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and specialized medical commodities across multiple therapeutic domains. The current award for Dupixent, a biologic treatment, exemplifies the company's role in providing specialty pharmaceutical products to federal military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FJ5Q2?
SPE2DR26FJ5Q2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FJ5Q2 worth?
The government has obligated $10,275 on SPE2DR26FJ5Q2.
Is contract SPE2DR26FJ5Q2 an order under another contract?
Yes. SPE2DR26FJ5Q2 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ5Q2 competed?
The extent of competition for SPE2DR26FJ5Q2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award